DAY ONE BIOPHARMS Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DAY ONE BIOPHARMS, and what generic alternatives to DAY ONE BIOPHARMS drugs are available?
DAY ONE BIOPHARMS has two approved drugs.
There are two US patents protecting DAY ONE BIOPHARMS drugs.
There are forty-eight patent family members on DAY ONE BIOPHARMS drugs in twenty-seven countries.
Summary for DAY ONE BIOPHARMS
International Patents: | 48 |
US Patents: | 2 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 2 |
Drugs and US Patents for DAY ONE BIOPHARMS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Day One Biopharms | OJEMDA | tovorafenib | TABLET;ORAL | 217700-001 | Apr 23, 2024 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
Day One Biopharms | OJEMDA | tovorafenib | TABLET;ORAL | 217700-001 | Apr 23, 2024 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
Day One Biopharms | OJEMDA | tovorafenib | TABLET;ORAL | 217700-001 | Apr 23, 2024 | RX | Yes | Yes | 8,293,752 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | ||
Day One Biopharms | OJEMDA | tovorafenib | TABLET;ORAL | 217700-001 | Apr 23, 2024 | RX | Yes | Yes | 10,426,782 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for DAY ONE BIOPHARMS Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Costa Rica | 20160483 | ⤷ Subscribe |
Dominican Republic | P2016000254 | ⤷ Subscribe |
Colombia | 2016003340 | ⤷ Subscribe |
South Korea | 101764076 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.